Piritramide
- Generic Name
- Piritramide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H34N4O
- CAS Number
- 302-41-0
- Unique Ingredient Identifier
- 4RP92LYZ2F
- Background
Piritramide is under investigation for the treatment of Colon Cancer and Minimal Residual Disease. Piritramide has been investigated for the supportive care of Pain, Postoperative and Postoperative Nausea and Vomiting.
- Associated Conditions
- Severe Pain
- Associated Therapies
- -
Large-scale Prospective Double-blind Randomized Controlled Trial of Pecs II Block for Breast Surgery
- First Posted Date
- 2015-09-09
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- GZA Ziekenhuizen Campus Sint-Augustinus
- Target Recruit Count
- 140
- Registration Number
- NCT02544282
- Locations
- 🇧🇪
GZA Sint Augustinus, Wilrijk, Antwerpen, Belgium
Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-12-11
- Last Posted Date
- 2019-03-13
- Target Recruit Count
- 60
- Registration Number
- NCT02314871
- Locations
- 🇨🇿
Brno University Hospital, Brno, Jihomoravsky Kraj, Czechia
🇨🇿T. Bata Regional Hospital Zlin, Zlin, Jihomoravsky Kraj, Czechia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath